1. Home
  2. EXPO vs ADPT Comparison

EXPO vs ADPT Comparison

Compare EXPO & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Exponent Inc.

EXPO

Exponent Inc.

HOLD

Current Price

$66.75

Market Cap

3.3B

ML Signal

HOLD

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

HOLD

Current Price

$16.13

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXPO
ADPT
Founded
1967
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
2.8B
IPO Year
1990
2019

Fundamental Metrics

Financial Performance
Metric
EXPO
ADPT
Price
$66.75
$16.13
Analyst Decision
Buy
Strong Buy
Analyst Count
3
9
Target Price
$90.50
$17.78
AVG Volume (30 Days)
463.6K
1.9M
Earning Date
02-05-2026
02-05-2026
Dividend Yield
1.86%
N/A
EPS Growth
N/A
N/A
EPS
2.07
N/A
Revenue
$536,760,000.00
$276,976,000.00
Revenue This Year
$12.18
N/A
Revenue Next Year
$8.47
$23.05
P/E Ratio
$32.27
N/A
Revenue Growth
3.52
54.77
52 Week Low
$63.81
$6.26
52 Week High
$91.41
$20.76

Technical Indicators

Market Signals
Indicator
EXPO
ADPT
Relative Strength Index (RSI) 38.40 35.89
Support Level $69.00 $14.85
Resistance Level $81.95 $17.98
Average True Range (ATR) 3.74 1.10
MACD -0.69 -0.35
Stochastic Oscillator 6.97 14.24

Price Performance

Historical Comparison
EXPO
ADPT

About EXPO Exponent Inc.

Exponent Inc is a science and engineering consulting firm that provides solutions to complex problems. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which account for the majority of revenue, provide servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

Share on Social Networks: